Form 4: Ginkgo Bioworks Insider Sells Shares for Tax Withholding
Insider Transaction Report
Reshma P. Shetty, a Director and 10% owner of Ginkgo Bioworks Holdings, Inc., reported a sale of 124,727 shares of Class A Common Stock on April 10, 2026, to cover tax withholding obligations related to vested performance-based restricted stock units.
Summary
- Reshma P. Shetty, a Director and 10% owner of Ginkgo Bioworks Holdings, Inc. (DNA), reported transactions on April 9 and April 10, 2026.
- On April 9, 2026, 251,786 shares of Class A Common Stock were acquired upon the vesting of performance-based restricted stock units (PSUs).
- On April 10, 2026, 124,727 shares of Class A Common Stock were disposed of at a price of $6.434 per share.
- This disposition was a 'sell to cover' transaction to satisfy tax withholding obligations associated with the vesting of PSUs.
- Following these transactions, Ms. Shetty beneficially owns 436,422 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the reported stock sale is a standard, non-discretionary transaction to cover tax obligations rather than an indicator of the insider's view on the company's future prospects.
Positives
- Vesting of 251,786 performance-based restricted stock units (PSUs) indicates achievement of performance targets.
- The 'sell to cover' transaction is a standard procedure for managing tax liabilities upon equity vesting and does not represent a discretionary sale.
Negatives
- A disposition of 124,727 shares of Class A Common Stock occurred, reducing the reporting person's direct holdings.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding future financial performance. It primarily reports on past transactions.
Management Comments
- Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person.
- The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a 'sell to cover' transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and are essential for understanding insider activity. The reported 'sell to cover' transaction for tax withholding is a common and expected event when performance-based equity awards vest, particularly for companies with significant stock-based compensation plans like those in the biotechnology sector.
Stakeholder Impact
- Shareholders: The sale of shares by an insider for tax purposes is a routine event and is not expected to have a significant impact on the share price. It does not reflect a change in the insider's fundamental view of the company.
Key Dates
| Date | Description |
|---|---|
| 04/09/2026 | Date of acquisition of Class A Common Stock upon vesting of performance-based restricted stock units. |
| 04/10/2026 | Date of disposition of Class A Common Stock to cover tax withholding obligations. |
| 04/13/2026 | Date of filing of the Form 4. |
| 06/19/2025 | Date of grant of 375,800 PSUs. |
| 01/01/2025 | Start date of the one-year performance period for PSUs. |
| 12/31/2025 | End date of the one-year performance period for PSUs. |
Keywords
Ginkgo Bioworks, DNA, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Vesting, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.